202 related articles for article (PubMed ID: 35278027)
1. Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.
Ricar J; Cetkovska P; Hordinsky M; Ricarova R
Dermatol Ther; 2022 Jun; 35(6):e15438. PubMed ID: 35278027
[TBL] [Abstract][Full Text] [Related]
2. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
3. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
Coronel-Pérez IM; Rodríguez-Rey EM; Camacho-Martínez FM
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
[TBL] [Abstract][Full Text] [Related]
4. Bimatoprost in the treatment of eyelash universalis alopecia areata.
Vila TO; Camacho Martinez FM
Int J Trichology; 2010 Jul; 2(2):86-8. PubMed ID: 21712909
[TBL] [Abstract][Full Text] [Related]
5. Bimatoprost in the treatment of eyelash hypotrichosis.
Law SK
Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
Ahluwalia GS
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
[TBL] [Abstract][Full Text] [Related]
7. Regrowth of upper eyelid eyelashes after making a surgical incision on the upper eyelid in a case of severe alopecia areata.
Ning B; Dharmasena A; Inkster C
Ophthalmic Plast Reconstr Surg; 2014; 30(1):e2-3. PubMed ID: 23467284
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects.
Borchert M; Bruce S; Wirta D; Yoelin SG; Lee S; Mao C; VanDenburgh A
Clin Ophthalmol; 2016; 10():419-29. PubMed ID: 27022239
[TBL] [Abstract][Full Text] [Related]
9. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
[TBL] [Abstract][Full Text] [Related]
10. Eyelash alopecia areata: case series and literature review.
Modjtahedi BS; Kishan AU; Schwab IR; Jackson WB; Maibach HI
Can J Ophthalmol; 2012 Aug; 47(4):333-8. PubMed ID: 22883840
[TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
[No Abstract] [Full Text] [Related]
12. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
Yoelin S; Walt JG; Earl M
Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
[TBL] [Abstract][Full Text] [Related]
13. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
[TBL] [Abstract][Full Text] [Related]
14. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
[TBL] [Abstract][Full Text] [Related]
15. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
Fagien S
Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
[TBL] [Abstract][Full Text] [Related]
16. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
Fagien S
Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
[TBL] [Abstract][Full Text] [Related]
17. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows.
Faghihi G; Andalib F; Asilian A
Eur J Dermatol; 2009; 19(6):586-7. PubMed ID: 19620039
[TBL] [Abstract][Full Text] [Related]
19. Long-term utility and durability of the therapeutic effects of bimatoprost 0.03% for eyelash augmentation in healthy Asian subjects.
Kwon O; Kim JY; Paik SH; Jeon HC; Jung YJ; Lee Y; Baek JH; Chun JH; Lee WS; Lee JY; Rogers JD; Halstead M; Eun HC
Dermatology; 2014; 229(3):222-9. PubMed ID: 25228046
[TBL] [Abstract][Full Text] [Related]
20. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
Ochoa BE; Sah D; Wang G; Stamper R; Price VH
J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
